Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$224.66 USD

224.66
822,666

-4.35 (-1.90%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $224.60 -0.06 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (2 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FNX

Acadia Healthcare (ACHC) Up 7.2% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Universal Health Services (UHS) Up 18.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Pediatrix (MD) Down 19% Since Q3 Earnings & Revenue Miss

by Zacks Equity Research

Pediatrix's (MD) Q3 results reflect volume constraints and an elevated expense level. Adjusted EBITDA is now expected within $240-$245 million, down from the earlier view of $260-$270 million.

Ensign Group (ENSG) Shares Up 2% Despite Q3 Earnings Miss

by Zacks Equity Research

Ensign Group's (ENSG) third-quarter results reflect strength in the Skilled Services segment. A hiked 2022 EPS guidance remains noteworthy. However, escalated expenses are bothersome.

Cigna (CI) Q3 Earnings Top on Evernorth Unit, 2022 EPS View Up

by Zacks Equity Research

Cigna's (CI) third-quarter results reflect strong pharmacy revenues coupled with solid segmental performances. A hiked 2022 EPS outlook is commendable.

Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit

by Zacks Equity Research

Humana's (HUM) third-quarter earnings gain from solid premiums and membership growth within its individual Medicare Advantage business coupled with a well-performing Healthcare Services segment.

Molina Healthcare (MOH) Q3 Earnings Top, 2022 EPS View Up

by Zacks Equity Research

Molina Healthcare's (MOH) third-quarter results reflect an expanding customer base within its Medicare and Medicaid businesses. Management hikes 2022 adjusted EPS guidance to a minimum of $17.75.

Universal Health (UHS) Q3 Earnings Top on Better Patient Volumes

by Zacks Equity Research

Universal Health's (UHS) third-quarter results reflect growing patient admissions at its segments. However, margins are hurt by escalated labor costs.

Universal Health Services (UHS) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Universal Health Services (UHS) delivered earnings and revenue surprises of 5.83% and 0.76%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Kaibalya Pravo Dey headshot

4 Stocks Navigating Through Hospital Industry Headwinds (Revised)

by Kaibalya Pravo Dey

Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.

Universal Health (UHS) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Universal Health's (UHS) Q3 results are likely to reflect sound segmental performances resulting from a constant pursuit of expansion moves. However, high labor costs might partly offset the results.

Zacks Industry Outlook Highlights HCA Healthcare, Acadia Healthcare, Universal Health Services and Tenet Healthcare

by Zacks Equity Research

HCA Healthcare, Acadia Healthcare, Universal Health Services and Tenet Healthcare have been highlighted in this Industry Outlook article.

Kaibalya Pravo Dey headshot

4 Stocks Navigating Through Hospital Industry Headwinds

by Kaibalya Pravo Dey

Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.

Earnings Preview: Universal Health Services (UHS) Q3 Earnings Expected to Decline

by Zacks Equity Research

Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Is Universal Health Services (UHS) Down 5.3% Since Last Earnings Report?

by Zacks Equity Research

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

UnitedHealth (UNH) Unit Adds Features to Surest Plans

by Zacks Equity Research

UnitedHealth Group's (UNH) arm UnitedHealthcare advances Surest plans by including features to lure more employers into opting for the attractive package and bolster its geographic reach.

Select Medical (SEM) Shares Dip on Q2 Earnings & Revenue Miss

by Zacks Equity Research

Select Medical's (SEM) second-quarter earnings take a hit from escalating expenses and reduced admissions within the Critical Illness Recovery Hospital segment.

Acadia Healthcare (ACHC) Stock Up 3% on Q2 Earnings Beat

by Zacks Equity Research

Acadia Healthcare's (ACHC) second-quarter results benefit from a strong-performing U.S. business. A raised 2022 guidance with respect to EPS bodes well.

Cigna (CI) Q2 Earnings Beat Estimates, Hikes '22 EPS View

by Zacks Equity Research

Cigna's (CI) second-quarter results indicate solid membership growth plus sound contributions from Evernorth and Cigna Healthcare segments. An upped 2022 EPS outlook remains noteworthy.

Molina Healthcare (MOH) Q2 Earnings Beat, Hikes '22 EPS View

by Zacks Equity Research

Molina Healthcare's (MOH) second-quarter results gain from membership growth within its Medicaid and Medicare lines of business. A hiked adjusted EPS guidance for 2022 is noteworthy.

Humana (HUM) Q2 Earnings Beat Estimates, Ups '22 EPS View

by Zacks Equity Research

Humana's (HUM) second-quarter earnings benefit from higher premiums and strong individual Medicare Advantage membership growth. A hiked adjusted EPS guidance for 2022 is noteworthy.

Universal Health (UHS) Q2 Earnings Beat on Strong Segments

by Zacks Equity Research

Universal Health's (UHS) second-quarter results benefit from strong contributions from Acute Care Hospital Services and Behavioral Health Care Services segments, partly offset by elevated operating costs.

Universal Health Services (UHS) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Universal Health Services (UHS) delivered earnings and revenue surprises of 5.77% and 0.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's How Universal Health (UHS) Looks Ahead of Q2 Earnings

by Zacks Equity Research

Universal Health's (UHS) second-quarter results are likely to benefit from sound contributions from Acute Care Hospital Services segment. Increased labor costs might partly hurt results.